Type 2 diabetes affects hundreds of millions of people worldwide and is one of the biggest risk factors for heart disease. Many patients eventually develop blocked arteries, heart attacks or strokes even while taking medicines to control blood sugar. Because of this, doctors are increasingly looking for treatments that improve both blood sugar and long-term heart health. Mounjaro, known by its generic name tirzepatide, is one of the newest diabetes medicines. It works by copying the effects of natural hormones that help regulate blood sugar, slow stomach emptying and reduce appetite.